Friday, December 9, 2011
08:30-10:00 |
OPENING SESSION |
| Chairpersons | J.H.Lang, China (Honorary Chairman) C.Q. Zhou, China G. Lu, China Z.J. Chen, China Z. Ben Rafael, Israel |
| 08:30-08:35 | Opening remarks |
| Experts views on where our field is heading | |
| 08:35-08:55 | Stem Cells and Their Significance in Gynecology C. De Geyter, Switzerland |
| 08:55-09:15 | Sperm fitness testing and experimental IVF on integrated Lab-on-a-Chip devices J. Cheng, K. Mitchelson, China |
09:15-10:00 |
WHEN WILL LAPAROSCOPY REPLACE ALMOST ALL LAPAROTOMIES? |
| Capsule | Video-Laparoscopy is developing fast, covering an ever growing number of operations and disciplines. Prof. Nezhat, often referred to as a "Wizard" in Laparoscopy, will present his personal view, an odyssey of science technology and will explain where Video-Laparoscopy is heading and if this technology will ever put to rest all laparotomies, and in his words: "The objectives of the lecture are, to motivate the younger physicians, bring hope to their work and education and encouragement in their careers" C.R. Nezhat, USA |
| 10:00-10:20 | Coffee break |
10:20-11:50 |
INCREASING CAESAREAN SECTION RATE: HOW MUCH IS TOO MUCH? |
| Capsule | One of the hottest controversies is the huge increase in CS rates worldwide. Viewed by some as a blessing and a modern response to obstetrics needs, others view it as a lack of discipline and understanding |
| Chairperson | W.H. Tam , Hong Kong H. Divakar, India |
| 10:20-11:20 |
Hot Topic: Increasing rates of CS the right way to go?
Is there a midway Between the view that “CS for all should be the target” and the view that “Understanding overall Caesarean section rates will help limit the rising rates” M. Robson, Ireland Discussion |
| 11:20-11:50 | LMWH for pregnancy loss: To treat or not to treat? I. Blickstein, Israel |
| Objectives: | To acquire knowledge on the following:
|
| 11:50-12:10 | Poster viewing |
12:10-13:40 |
CONTROVERSIES IN PRETERM LABOR AND DELIVERY |
| Capsule | Despite the high fetal morbidity and mortality that is associated with premature delivery, there is currently neither a tool specific enough to diagnose premature labor, nor a good intervention available to effectively interrupt the vicious circle of labor |
| Chairpersons | W.H. Tam, Hong Kong W. Holzgreve, Switzerland |
| 12:10-12:40 | Diagnosis of preterm labor (PTL) and prediction of premature delivery (PMD): Who to treat, and who not to treat? I. Blickstein, Israel |
| 12:40-13:10 | Why do we use tocolysis at all? M. Robson, Ireland |
| 13:10-13:40 | Should we repeat atosiban tocolysis as frequently as required? I. Blickstein, Israel |
| Objectives: | Upon completion of this session, the audience will have learned:
|
| 13:40-14:30 | Lunch break |
14:30-16:00 |
GESTATIONAL DIABETES MELLITUS (GDM) |
| Capsule | The association of milder forms of GDM with perinatal morbidity and mortality remains unclear, primarily because the condition is often confounded with other risk factors, such as maternal obesity, age, and parity which increase the risks of adverse pregnancy outcomes. The implementation of the HAPO results into recommendations increases the number of patients labeled to have GDM from 4% to16%. While many would welcome the doubling of patients load the question is, will increased expenditure improve the outcome? |
| Chairperson | I. Blickstein, Israel W. Holzgreve, Switzerland |
| 14:30-15:15 | The Pros and Cons surrounding the Implementation of HAPO study recommendations: Will it increase the safety of pregnancy or just increase the number of patients labeled as GDM W.H. Tam, Hong Kong (TBC) |
| Discussant W.H. Tam, Hong Kong |
|
| 15:15-15:30 | Questions to the panel
|
| 15:30-16:00 | Active Management of Labour: What is the evidence? M. Robson, Ireland |
| Objectives: | To acquire knowledge on the following:
|
| 16:00-16:30 | Coffee break |
16:30-18:00 |
PRENATAL DIAGNOSIS |
| Capsule | Prenatal diagnosis is evolving fast, and soon we'll be able to get a full noninvasive screening |
| Chairpersons | T.Y. Leung, Hong Kong W. Holzgreve, Switzerland |
| 16:30-16:50 | Non-invasive prenatal diagnosis from maternal blood: Finally available in clinical practice after 20 years of research W. Holzgreve, Switzerland |
| 16:50-17:15 | Is there any role of NT and biochemical screening in the era of non-invasive prenatal diagnosis? T.Y. Leung , Hong Kong |
| 17:15-17:40 | Evaluation of the cervix with new wireless device W. Holzgreve, Switzerland |
| 17:40-18:00 | Comparative genomic hybridization-array analysis enhances the detection of aneuploidies and submicroscopic imbalances in spontaneous miscarriages K.W.R. Choy, Hong Kong |
| Objectives: | To acquire knowledge on the following:
|
| 18:30-19:45 | Special entertaining performance of “Snakes, Bugs and Us” By “Skip” Granai, MD, USA |
Saturday, December 10, 2011
08:30-09:00 |
COMPLICATIONS OR PREGNANCY AND DELIVERY |
| Capsule | Life-threatening situations in obstetrics should be identified and treated early |
| Chairpersons | W.H. Tam, Hong Kong (TBC) I. Blickstein, Israel |
| 08:30-09:00 | New insights into the pathophysiology of preeclampsia: Consequences for prediction and prevention W. Holzgreve, Switzerland |
| 09:00-09:30 | What is the best maneuver to relieve shoulder dystocia and safety limit for head-to-body delivery interval? T.Y. Leung, Hong Kong |
| 09:30-10:00 | Stem cells from cord blood and other sources: What the obstetricians/ gynecologists should know? W. Holzgreve, Switzerland |
| Objectives: | Upon completion of this session, the audience will have learned:
|
| 10:00-10:20 | Coffee break |
10:20-11:50 |
CERCLAGE |
| Capsule | Cerclage is being used in increasing frequency despite the lack of RCT |
| Chairpersons | T.Y. Leung, Hong Kong H. Divakar, India |
| 10:20-11:20 |
Debate: Does Cervical Cerclage with Bulging Membranes Extend Pregnancy Beyond Conservative Treatment? What is the Evidence?
No Evidence: Conservative treatment will achieve similar results. The risk of infection is too high to keep experimenting I. Blickstein, Israel Selection of patients and meticulous technique is the key to success in emergency cerclage W.H. Tam, Hong Kong Discussion |
| 11:20-11:50 | The role of “repeated dose” steroids T.Y. Leung, Hong Kong |
| Objectives | Upon completion of this session, the audience will have learned:
|
| 11:50-12:10 | Poster viewing |
12:10-13:40 |
MULTIPLE PREGNANCIES |
| Capsule | The modern epidemic of multiple pregnancies might have many reasons but has one profound effect on perinatal results. Recognizing the risk might be the first step for prevention |
| Chairpersons | M. Robson, Ireland W.H. Tam, Hong Kong |
| 12:10-12:40 | How do iatrogenic multiple pregnancies complicate perinatal care? I. Blickstein, Israel |
| 12:40-13:10 | Fetoscopic Laser treatment of twin to twin transfusion syndrome: More than "see and burn" T.Y. Leung, Hong Kong |
| 13:10-13:40 | Selective IUGR in twins S. Luming, China |
| Objectives: | Upon completion of this session, the audience will have learned:
|
| 13:40-14:30 | Lunch break |
14:30-16:00 |
HIGH RISK PREGNANCIES IN ART: A PRICE TO PAY
|
| Capsule | It seems as if there are two monologues are going on simultaneously; ART- specialists are opting for the highest pregnancy rates defying the limitations on reproduction set by nature on male and female fertility. On the other hand, age, female chronic diseases, multiple pregnancies, and parental genetic deficiencies have opened a whole new field of "ART high risk pregnancies" opting to secure the safest delivery and perinatal outcome in these extreme situations. Conversely, an open dialogue, which will allow the perinatologists to influence the "point of entry" to ART treatments, might result in higher barriers on personal rights to peruse their plans. What kind of dialogue should we develop? |
| Chairpersons | Z. Ben-Rafael, Israel H. Divakar, India |
| 14:30-15:00 | Medical complications of pregnancy resulting from IVF: What do we know and what don’t we know? I. Blickstein, Israel |
| 15:00-16:00 |
Debate: Preconception counseling for ART: who should inform the women about the risks?
Proposition: Patients are ready to take the many risk in their journey to parenthoods, and ART specialists are fully trained, to weigh the risk/benefit in most situations, hence they should be the primary physicians to provide counseling N. Gleicher, USA Opposition: ART specialists might be in conflict when counseling women on the plethora of perinatal risks that they might face I. Blickstein, Israel Discussion: What kind of dialogue should we develop? |
| Objectives: | Upon completion of this session, the audience will have learned:
|
16:30-18:00 |
COMPLICATIONS OF PREGNANCY (II) |
| Chairpersons | H. Divakar, India T.Y. Leung, Hong Kong |
| 16:30-17:00 | New drugs to reduce post-partum hemorrhage I. Blickstein, Israel |
| 17:00-17:30 | Reducing maternal anemia in the 3rd world H. Divakar, India |
| 17:30-18:00 | Myomectomy during CS Z. Ben Rafael, Israel |
| Objectives: | Upon completion of this session, the audience will have learned:
|